Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
ConforMIS today set the terms for its forthcoming initial public offering, saying it plans to float 9 million shares at $14 to $16 apiece.
At the midpoint of the range, the IPO would fetch $135 million. Read more
Medtronic said it took out a stake with an option to buy on Arsenal Medical and its hemostatic foam.
Arsenals is developing the foam and a delivery system that are designed to reduce the chance of endoleaks after the placement of a stent graft to treat an abdominal aortic aneurysm. Read more
Speed is more important than size, when it comes to succeeding in the competitive medical device market, president & CEO Mike Mahoney said last night at the DeviceTalks Boston event.
Mahoney said that while being big helped, it wasn’t the key to success – speed, a winning spirit culture, growth and category leadership were at the heart of what keeps the company on the top of its game. Read more